Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $9.0600 (2.95%) ($9.0600 - $9.0600) on Fri. Mar. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 42.02% (three month average) | RSI | 50 | Latest Price | $9.0600(2.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -9.6% a day on average for past five trading days. | Weekly Trend | EYES declines -12.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) KWEB(40%) MCHI(39%) VIXM(38%) FXI(33%) VXX(29%) | Factors Impacting EYES price | EYES will decline at least -21.01% in a week (0% probabilities). CEMB(-99%) TIP(-42%) JNK(-40%) TLT(-39%) VCIT(-33%) | | | | | Relative Volatility | | | | Market Trend Strength | -21.01% (StdDev 42.02%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $10.12 | 5 Day Moving Average | $10.03(-9.67%) | 10 Day Moving Average | $12.04(-24.75%) | 20 Day Moving Average | $10.12(-10.47%) | To recent high | -41.5% | To recent low | 56.5% | Market Cap | $2.894b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |